Apollon Wealth Management, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 1 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Apollon Wealth Management, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,890
-12.9%
10,0000.0%0.00%
Q2 2023$4,465
-45.5%
10,0000.0%0.00%
-100.0%
Q1 2023$8,200
-47.4%
10,0000.0%0.00%0.0%
Q4 2022$15,600
-8.2%
10,0000.0%0.00%0.0%
Q3 2022$17,0000.0%10,0000.0%0.00%0.0%
Q2 2022$17,000
-52.8%
10,0000.0%0.00%
-66.7%
Q1 2022$36,000
-52.6%
10,000
-6.3%
0.00%
-70.0%
Q3 2021$76,00010,6750.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Sante Capital Fund, LP 115,637$1,072,0000.44%
Defender Capital, LLC. 135,466$1,255,0000.42%
Green Alpha Advisors, LLC 62,566$580,0000.40%
Harvest Investment Services, LLC 51,239$474,0000.20%
SEVEN EIGHT CAPITAL, LP 118,270$1,096,0000.15%
Cedar Brook Financial Partners, LLC 54,500$505,0000.15%
WASATCH ADVISORS LP 3,576,706$33,156,0000.14%
Banco BTG Pactual S.A. 20,000$185,0000.12%
Keystone Financial Group 60,712$563,0000.10%
Virtus ETF Advisers LLC 25,105$233,0000.10%
View complete list of INOVIO PHARMACEUTICALS INC shareholders